Teleflex Competitors and Similar CompaniesClear all
Inari Medical's competitors and similar companies include Sonova and Glaukos.
 Inari Medical Inari Medical (formerly known as Inceptus Newco1) is a medical device company focused on developing products to treat and transform patients suffering from venous diseases. |  Glaukos Glaukos is an ophthalmic medical technology and pharmaceutical company that develops therapies for treating glaucoma, corneal disorders, and retinal diseases. | ||
Founding Date | Founding Date 2011 | Founding Date 1947 | Founding Date 1998 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Irvine, US HQ | Locations Stäfa, CH HQ Mc Mahons Point, AU Sydney, AU Himmelreich, AT Linz, AT Dilbeek, BE Sao Paulo, BR see more | Locations Aliso Viejo, US HQ Buenos Aires, AR Heatherton, AU Sao Paulo, BR Richmond Hill, CA San José, CR Wiesbaden, DE see more |
Employees | Employees 1,10038% increase | Employees 18,335 | Employees 90716% increase |
Valuation ($) | Valuation ($) 2.9 b | Valuation ($) N/A | Valuation ($) 7.6 b |
Financial | |||
Revenue (est.) | Revenue (est.) $493.6m (FY, 2023) | Revenue (est.) CHF3.6b (FY, 2026) | Revenue (est.) $507.4m (FY, 2025) |
Cost of goods | Cost of goods $59.1m (FY, 2023) | Cost of goods CHF669.9m (FY, 2026) | Cost of goods $111.8m (FY, 2025) |
Gross profit | Gross profit $434.6m (FY, 2023) | Gross profit CHF2.9b (FY, 2026) | Gross profit $282.8m (FY, 2025) |
Net income | Net income ($1.6m) (FY, 2023) | Net income CHF546m (FY, 2026) | Net income ($187.7m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 44.1m | Total funding raised N/A | Total funding raised $ 115m |
For sources of this data, please see the company profile
View Company Profiles
Sonova
HQ
Stäfa, CH
Employees
18,335
Sonova is a company that provides hearing care solutions.
View companyGlaukos
HQ
Aliso Viejo, US
Employees
907↑ 16% increase
Glaukos is an ophthalmic medical technology and pharmaceutical company that develops therapies for treating glaucoma, corneal disorders, and retinal diseases.
View company